NOV Inc. (NOV) Market Cap & Valuation Ratios
NOV Inc. (NOV) has a market cap of $7.0B, a trailing P/E of 73.2 and a price-to-sales ratio of 0.8, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NOVNOV Inc.Follow NOV — free
—
Price chart with a free account
- Market cap
- 7.0B
- P/E TTM
- 73.2
- Dividend yield
- 2.1%
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Peers
oil & gas equipment & services · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| NOV | 7.0 | 73.2 | 0.9 | 9.4 | 8.0% | -2% | 5% | 3% |
| WFRD | 6.3 | 15.5 | 1.4 | 7.6 | 9.2% | -6% | 12% | 25% |
| AROC | 5.1 | 15.7 | 5.0 | 8.5 | 5.7% | +12% | 40% | 11% |
| WHD | 5.1 | — | 3.4 | 13.1 | 6.4% | +22% | 19% | 24% |
| SEI | 4.5 | — | 8.1 | 20.9 | — | +71% | 24% | 5% |
| KGS | 4.5 | 52.8 | 5.1 | 10.6 | 0.1% | +8% | 27% | 6% |
| TDW | 4.3 | — | 3.2 | 10.8 | 6.3% | -1% | 18% | 14% |
| OII | 3.9 | 12.0 | 1.3 | 8.9 | 7.4% | +3% | 10% | 25% |
| WBI | 3.7 | — | 7.0 | 16.8 | -3.3% | +103% | 16% | 4% |
| LBRT | 2.5 | 65.0 | 0.8 | 6.9 | — | +14% | 2% | 2% |
| WTTR | 2.5 | 64.8 | 1.9 | 11.3 | -3.3% | -2% | 4% | 3% |
| Median of these 10 | 34.2 | 3.3 | 10.7 | 6.0% | +10% | 17% | 9% |
P/E 73.2 vs. a peer median of 34.2; EV/Sales 0.9 vs. 3.3. NOV's own P/E sits at the 81st percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesWHD and SEI and TDW and WBI have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
NOV Inc. — questions
- What is NOV Inc.'s market cap?
- $7.0B.
- What is NOV Inc.'s P/E ratio?
- 73.2 on trailing twelve-month earnings to 2026-06-30.
- What is NOV Inc.'s price-to-sales ratio?
- 0.8.
Every figure on this page comes from NOV Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.